Taftaf Ahmad, Vera Cruz Claudine A, Al-Qasmi Haytham, Al-Qasmi Mohammed
Internal Medicine, Hurley Medical Center, Flint, USA.
Neurology, Michigan State University College of Human Medicine, Flint, USA.
Cureus. 2024 Jun 30;16(6):e63498. doi: 10.7759/cureus.63498. eCollection 2024 Jun.
Coronavirus disease (COVID-19) has been associated with a diverse range of extrapulmonary manifestations since its global outbreak in 2019. One of its rare complications is Guillain-Barre Syndrome (GBS), a post-infectious neurological disorder that manifests with a characteristic ascending limb paralysis. Here, we describe the atypical case of a 42-year-old African American male who developed bilateral facial paralysis within five weeks of testing positive for COVID-19. Initial diagnostic imaging and blood studies were negative for acute pathology. Albuminocytological dissociation found in a subsequent analysis of the patient's cerebrospinal fluid and his appropriate therapeutic response to intravenous immunoglobulin (IVIg) indicated GBS as the most likely diagnosis.
自2019年全球爆发以来,冠状病毒病(COVID-19)已与多种肺外表现相关联。其罕见并发症之一是吉兰-巴雷综合征(GBS),这是一种感染后神经疾病,表现为典型的上行性肢体麻痹。在此,我们描述了一例非典型病例,一名42岁非裔美国男性在COVID-19检测呈阳性后的五周内出现双侧面部麻痹。最初的诊断性影像学检查和血液研究未发现急性病变。随后对患者脑脊液的分析中发现蛋白细胞分离现象,且患者对静脉注射免疫球蛋白(IVIg)有适当的治疗反应,这表明最可能的诊断为GBS。